Michael Tung | IR Executive |
Enrique Conterno | CEO & Director |
Juan Graham | CFO |
Mark Eisner | EVP & Chief Medical Officer |
Thane Wettig | EVP & Chief Commercial Officer |
Christine Chung | SVP, China Operations |
Jason Gerberry | Bank of America Merrill Lynch |
Jack Padovano | Stifel, Nicolaus & Company |
Michael Yee | Jefferies |
Alexander Nackenoff | Raymond James & Associates |
Andy Hsieh | William Blair & Company |
Yaron Werber | Cowen |
Paul Choi | Goldman Sachs |
Good day, and thank you for standing by. Welcome to FibroGen's Third Quarter 2022 Earnings Call. [Operator Instructions]. I would now like to hand the conference over to today's speaker, Michael Tung, Vice President of Corporate Strategy and Investor Relations. The floor is yours.